The transcription factor AP-2α (TFAP2A), a RA-inducible gene with tumor-suppressing activity [47, 48], was upregulated by CRABP1 depletion and RA treatment at a dose up to 5 nM. This evidence concerns the gene TFAP2A and neoplasm.